Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

but rather a sort of side benefit of GLP-1 agonists. The researcher likened the drug’s effect on those conditions to “a side gig. Nobody designed GLP-1s to reduce Alzheimer’s disease.” Nigel Greig, ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...